OR WAIT null SECS
January 11, 2023
Ipsen’s $952 million acquisition of Albireo is designed to bolster the company's rare disease portfolio.
Sartorius and RoosterBio will work together to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies.
January 10, 2023
Getinge is launching Livit Flex, a bioprocess control system designed to help pharmaceutical and biotech products get to market faster.
The collaboration will see Moderna and CytomX work together to develop mRNA-based conditionally activated therapeutics.
Eisai’s Alzheimer’s treatment, Leqembi (lecanemab-irmb), received approval from FDA via the Accelerated Approval pathway.
January 09, 2023
Astrea Bioseparations has acquired Delta Precision, a manufacturer of chromatography columns for biomanufacturing.
Avantor and Catalent have entered into a multi-year supply and services agreement.
January 05, 2023
The agency revised a regulation to enable pharmacies to dispense mifepristone directly to individuals with a prescription.
January 02, 2023
As the therapeutic landscape grows more complex, so too must the analytical techniques for cleaning validation to ensure the utmost cleanliness is achieved.
In light of increasingly stringent sustainability requirements, bio/pharma companies need to make sure they formulate effective ESG strategies.